Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

67.01
+1.542.35%
Post-market: 67.020.0100+0.01%19:59 EDT
Volume:6.84M
Turnover:457.82M
Market Cap:136.42B
PE:14.75
High:67.55
Open:65.79
Low:65.13
Close:65.47
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.72
T/O Rate:0.34%
Dividend:2.51
Dividend Rate:3.74%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.11
PE(LYR):19.37

Loading ...

Bristol-Myers Squibb: Strong Quarter and Higher Eliquis Growth Outlook Offset by Legacy Declines and Pipeline Delays, Supporting Hold Rating

TIPRANKS
·
Jul 30

Dow Jones Top Company Headlines at 11 am ET: Amazon's Zoox Gets Clearance to Start Paid Robotaxi Rides | NYSE ...

Dow Jones
·
Jul 30

Movement Alert|Bristol-Myers Squibb Rises 3.07% in Regular Trading, Q2 Earnings Massively Beat Expectations with Full-Year Guidance Sharply Raised

Market Focus
·
Jul 30

Bristol Myers Squibb Exec Says Expects Late-Stage Data from Milvexian Atrial Fibrillation Trial in Q1 2027, Compared with Late 2026 Announced Previously - Conf Call

THOMSON REUTERS
·
Jul 30

Bristol Myers Squibb CEO Says Updated Timing in Milvexian Trial Reflects the Pace of Events

THOMSON REUTERS
·
Jul 30

Bristol Myers CEO Expects Top-Line Data Readouts from Cobenfy Alzheimer’s Disease Psychosis Study to Begin in Early 2027 and be Spread Across the Year

THOMSON REUTERS
·
Jul 30

Bristol Myers CEO Says Potential Interim Analysis for Adept 1 Trial Could Come Later This Year

THOMSON REUTERS
·
Jul 30

Bristol Myers Q2 Adjusted EPS $2.04 Versus IBES Estimate $1.59

Reuters
·
Jul 30

Bristol Myers Q2 GAAP EPS Rises to 1.62; Revenue Increases 5.7% to 13 Billion

Reuters
·
Jul 30

Bristol Myers Raises Earnings Guidance as Newer Drugs Drive Big Quarterly Beat

Dow Jones
·
Jul 30

Bristol Myers Squibb Posts Fiscal Q2 2026 Earnings Release, Investor Presentation Online

Reuters
·
Jul 30

Earnings Flash (BMY) Bristol-Myers Squibb Posts Q2 Revenue $12.97B, vs. FactSet Est of $11.74B

MT Newswires Live
·
Jul 30

Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate

Benzinga Earnings
·
Jul 30

Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

THOMSON REUTERS
·
Jul 30

Bristol Myers Q2 REV $12.97 Bln vs Ibes Estimate $11.75 Bln

THOMSON REUTERS
·
Jul 30

Bristol Myers Outlook FY Eliquis REV Growth 20%-25% vs Prior Forecast of 10%-15%

THOMSON REUTERS
·
Jul 30

Bristol Myers Raises 2026 Forecast as Eliquis, Newer Medicines Power Results

Reuters
·
Jul 30

Cytokinetics Wins UK Approval, NICE Backing for Heart Disease Drug

Reuters
·
Jul 30

U.S. Earnings Preview: Before Market Open July 30

Dow Jones
·
Jul 30

How To Earn $500 A Month From Bristol-Myers Squibb Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Jul 29